Zdrowie i gospodarka · 04/02/2022

FDA Proposes Updates to Prescription Drug Marketing Regulations

The Food and Drug Administration (FDA) is proposing to update its prescription drug marketing regulations to align with changes to the Federal Food, Drug, and Cosmetic Act (FD&C Act) resulting from the enactment of the Drug Supply Chain Security Act (DSCSA). This change aims to remove outdated and conflicting requirements to ensure compliance with the updated provisions.